ERBB2 and cancer: The top over-represented canonical signaling pathways included modulation in commonly observed “Cancer” signatures, such as the regulation of matrix metalloproteases, cancer metastasis signaling, HIF1α signaling, and HER-2 signaling (Fig. 3b).